All acutely and chronically sick patients, as well as parents and healthcare professionals.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: Children aged 6-<12 y, adolescents aged 12-<18 y, parents of paediatric patients aged 0-<18 y, health care professionals (nurses and paediatricians) taking care of paediatric patients aged 0-<18 y 2. Sex: For paediatric patients only: male or female 3. Health: For paediatric patients only: acutely or chronically sick. For parents and health care professionals: taking care of acutely or chronically sick children/adolescents the definition by Mokkink LB et. al, a participant is considered to be chronically sick if the underlying disease or condition lasts 3 months or more or has occurred 3 times or more during the past year and will probably reoccur. It affects a child’s normal activities and requires frequent hospitalisations, home health care, and/or extensive medical care. The underlying disease or condition is not (yet) curable or is highly resistant to treatment. 4. Compliance: Participant must understand and be willing, able, and likely to comply with the survey procedures. Participant must be able to understand the questions 5. Consent: Participant has verbally confirmed his/her consent, documented with a cross on the CRF by the investigator. For children and adolescent: the parent has verbally indicated his/her consent, documented with a cross on the CRF by the investigator 6. Affiliation: Participant must be either patient or parent of a patient at the Department of General Paediatrics, Neonatology and Paediatric Cardiology of the University Hospital Düsseldorf Or Participants must be a health care professional (nurse or paediatrician) employed at the Department of General Paediatrics, Neonatology and Paediatric Cardiology of the University Hospital Düsseldorf
Exclusion criteria
Exclusion criteria: For paediatric patients aged 6-<18 y: not fully oriented, e.g. in the post-operative period and not yet fully awoke
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify the maximum amount of 2 mm mini-tablets children aged 6-<12 y and adolescents aged 12-<18 y would be willing to take To identify the maximum amount of 3 mm mini-tablets children aged 6-<12 y and adolescents aged 12-<18 y would be willing to take | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify the maximum amount of 2 mm mini-tablets parents of children aged 0-<2 y and 2-<6 y would be willing to administer To identify the maximum amount of 3 mm mini-tablets parents of children aged 0-<2 y and 2-<6 y would be willing to administer To identify the maximum amount of 2 mm mini-tablets nurses would be willing to administer to paediatric patients aged 0-<2 y, 2-<6 y, 6-<12 y, and 12-<18 y To identify the maximum amount of 3 mm mini-tablets paediatricians would be willing to administer to paediatric patients aged 0-<2 y, 2-<6 y, 6-<12 y, and 12-<18 y | — |
Countries
Germany
Contacts
Universitätsklinikum Düsseldorf, Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie